Kolkata: The team of scientists, including two of the cities, has succeeded in developing various “thermosted” insulin, which eliminates the need to make it cooled.
This development is seen as a breakthrough in a scientific circle because, over the years now, portability has become the biggest obstacle for diabetics that depend on insulin.
This research was led by two scientists from the Bose Institute and Institute of Chemical Biology (IICB) in the city and two others from the Indian Chemical Technology Institute (IICT), Hyderabad.
“You will be able to keep it outside the refrigerator as long as you want, something that will help diabetics throughout the world, because bringing insulin together with them is considered very impractical,” said Subhrangsu Chatterjee, a faculty member at the Bose Institute.
“Although for now we call it ‘Insu-Lock’, we are in the process of attracting DST (Department of Science and Technology) to call it after Acharya Jagadish Chandra Bose,” he added.
This research has been praised by Istience, the International Journal of Sciences.
Chatterjee and Partha Chakrabarti, a faculty member at IICB, along with B Jagadeesh and J Reddy, can introduce the matrix of the four amino acidic acid molecules in insulin molecules, which prevent compaction of insulin molecules even when it is not cooled.
While insulin must now be stored at an ideal temperature of 4 ° C, this new variety will be able to withstand temperatures of up to 65 ° C, the researchers claims.
This four-year study into the structural design of Insu-Lock is funded together by the DST and the Scientific and Industrial Research Council (CSIR).
“While urban-rich diabetes patients can still regulate to negotiate their lives around the fragile insulin properties, can you imagine the fate of the vast and less capable rural population that has no way back for cooling?” Chatterjee said, explaining that insulin degeneration stored outside the cooling began six hours later.
After 12 hours of staying in normal room temperature, reaching the stage where it becomes not worthy of use.
“That’s why it’s very expensive.
We hope that DST and CSIR will now help us go for the company’s tie-up for mass production,” he told Toi.
According to rough estimates available for scientists, around eight crore people in the country were influenced by diabetes.
In Kolkata, about 13% of the population is diabetes, half depends on insulin injection.